Search through all our worldwide HIV and AIDS news and features, using the topics below to filter your results by subjects including HIV treatment, transmission and prevention, and hepatitis and TB co-infections.

TB treatment news

Show

From To
AIDS 2018: Price of bedaquiline drops in South Africa, will replace injectable TB drugs, Minister of Health announces

South Africa has signed a deal with bedaquiline manufacturer Jannsen pharmaceuticals to drop the price of the drug from $750 for a full course to $400, for the next eight months,Minister of Health Aaron Motsoaledi announced here today.

Published
23 July 2018
From
Science Speaks
Higher doses of rifampin appear more effective in fighting TB without increasing risk of adverse events

Higher daily doses of rifampin, a cornerstone of tuberculosis treatment, killed more TB bacteria in sputum cultures, and the higher doses did so without increasing the adverse effects of treatment, according to a randomized controlled trial published online in the American Thoracic Society's American Journal of Respiratory and Critical Care Medicine.

Published
29 June 2018
From
Eurekalert Inf Dis
Could a New Universal Tuberculosis Regimen Help End the TB Pandemic?

As tuberculosis (TB) is the world's most lethal infectious disease, there is an urgent need to improve the treatment of this bacterial infection. One approach under consideration is the institution of a universal or “pan-TB” regimen comprising new agents capable of treating multidrug-resistant (MDR) and even extensively drug-resistant (XDR) TB.

Published
29 May 2018
From
Infectious Disease Advisor
Smartphone app keeps an 'eye' on daily tuberculosis therapy

Johns Hopkins researchers report success with a smart phone video-based app that substitutes for a daily in-person visit by a health care worker required for tuberculosis treatment known as directly observed therapy, or DOT. The preliminary study showed that the app may be less costly and may improve privacy concerns raised by patients compared to in-person visits.

Published
27 April 2018
From
Eurekalert Inf Dis
TB Treatment May Leave Some Patients Contagious

The World Health Organization’s dosage guidelines for two leading tuberculosis medications may be far too low for patients with H.I.V., allowing them to remain contagious for longer than necessary, a new study has found.

Published
09 April 2018
From
New York Times
Higher rifampin doses safe for patients with pulmonary TB

Results of a phase 2 randomized clinical trial show that up to twice the standard daily dose of rifampin was safe in patients with pulmonary tuberculosis. The findings suggest that TB therapy can be shortened using higher doses, which could potentially improve outcomes without increasing toxicity.

Published
07 March 2018
From
Healio
Twice-daily dolutegravir is safe and effective when used alongside TB treatment

Twice-daily dosing of dolutegravir when combined with the tuberculosis (TB) drug rifampicin is safe and effective and will allow dolutegravir to be used alongside TB treatment as

Published
07 March 2018
By
Keith Alcorn
Know Your Rights: Tuberculosis Prevention, Diagnosis, and Treatment Guide

This guide is for people who have tuberculosis (TB), people who are at risk for it, and the people who take care of them. It explains what global standards are for TB prevention, treatment, and care, so you can know what services you have the right to receive.

Published
06 February 2018
From
Treatment Action Group
Tuberculosis drugs work better with vitamin C: US study

Tuberculosis patients may have a quicker way to recover. A U.S. new study in mice and in tissue cultures suggested that giving vitamin C with tuberculosis drugs could reduce the unusually long time it took these drugs to eradicate this pathogen.

Published
04 January 2018
From
Xinhua
3 innovations that could transform TB diagnosis and care

Ending global tuberculosis will require new diagnostic tools, new ways to support adherence to treatment, new drug regimens, and a vaccine, experts told Devex at the 48th Union World Conference on Lung Health.

Published
18 October 2017
From
Devex

Filter by country

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.